Banasco, Janebeth ..
HRN: 21-23-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2022
CEFUROXIME 1.5GM (VIAL)
04/12/2022
04/18/2022
IV
1.5 THEN 750MG
LD THEN Q8
PUS CELLS 16-20
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Dose 1.5g All Throughout The Tx Course (NAG)
Final appropriateness: No Wrong Dose
Overall appropriateness: No